  
 
            BLOOD TESTS • DIAGNOSTICS • WELLNESS  
 
 
 
 
 
 
 
Metropolis Healthcare Limited  
 
 
Registered & Corporate Office: 250 D, Udyog Bhavan, Hind Cycle Marg, Worli, Mumbai - 400 030. 
 
 
CIN: L73100MH2000PLC192798 Tel No.: 8422 801 801 Email: support@metropolisindia.com 
 
 
Website: www.metropolisindia.com 
 
 
Global Reference Laboratory: 4th Floor, Commercial Building-1A, Kohinoor Mall, Vidyavihar (W), Mumbai - 400 070. 
 
 
 
 
 
 
 
 
 
      
     Ref: MHL/Sec&Legal/2023-24/33 
 
 
 
                                Date: July 24, 2023 
 
To, 
Head, Listing Compliance Department 
BSE Limited, 
Phiroze Jeejeebhoy Towers, 
Dalal Street, Mumbai – 400 001. 
 
 
Scrip Code: 542650 
To,  
Head, Listing Compliance Department, 
National Stock Exchange of India Limited 
Exchange Plaza, Plot No. C/1. G Block, 
Bandra – Kurla Complex, Bandra (East), 
Mumbai – 400051 
 
Scrip Symbol: METROPOLIS 
 
Sub: Business Responsibility and Sustainability Reporting for the Financial Year 2022-23  
 
Ref: Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) 
Regulations, 2015. 
 
Dear Sir/ Madam, 
 
We are submitting herewith the Business Responsibility and Sustainability Report for financial 
year (‘FY’) 2022-23, which also forms part of the Annual Report for FY 2022-23, submitted to the 
Exchanges vide letter no. MHL/Sec&Legal/2023-24/32. 
 
Kindly take the aforesaid on record 
 
Thanking you, 
 
Yours faithfully 
For Metropolis Healthcare Limited 
 
 
 
Neha Shah 
Interim Company Secretary & 
Compliance Officer 
 
Membership No. A 51465 
Encl. a/a 
 
 
 
Neha 
Dilip Shah
Digitally signed by Neha Dilip Shah 
DN: c=IN, o=Personal, title=5014, 
pseudonym=936FEDDB600012A69DB715
614211E666EA969551, 
2.5.4.20=fad024c35dbc8a86181e3d4f34d0
f56e07b4309cb119a49896f8f36943955afd
, postalCode=400064, st=Maharashtra, 
serialNumber=FEB9E82688FCA5A64C82BF
EB23815EE851533EE6F9EC13C3148D8EB0
F9F27734, cn=Neha Dilip Shah 
Date: 2023.07.24 23:43:07 +05'30'
Statutory 
Reports
Annual Report 2022-23
69
SECTION A- GENERAL DISCLOSURES
BUSINESS 
RESPONSIBILITY & 
SUSTAINABILITY  
REPORT
I. Details of the listed entity
I-1. 
Corporate Identity Number (CIN) of the listed entity 
L73100MH2000PLC192798
I-2. 
Name of the listed entity 
Metropolis Healthcare Limited
I-3. 
Year of incorporation 
2000
I-4.
250-D, Udyog Bhavan, Worli, Mumbai - 
400 030, Maharashtra
I-5.
Corporate address
NA
I-6.
E-mail
secretarial@metropolisindia.com
I-7.
Telephone
(+91 22) 6258 2810
I-8.
Website
https://www.metropolisindia.com/
I-9.
Financial year for which reporting is being done
FY 2022-23
I-10.
Name of the Stock Exchange(s) where shares are listed
National Stock Exchange of India Limited 
and Bombay Stock Exchange Limited.
I-11.
Paid-up Capital
Rs. 10,24,21,328 divided into 
5,12,10,664 equity shares of face value 
of Rs. 2/- each
I-12.
Name and contact details (telephone, email address) of the 
person who may be contacted in case of any queries on the 
BRSR report:
Mr. Rakesh Agarwal, Chief Financial 
secretarial@metropolisindia.com, 
(+91 22) 6258 2810
I-13. 
Reporting boundary - Are the disclosures under this report 
made on a standalone basis (i.e. only for the entity) or on a 
consolidated basis (i.e. for the entity and all the entities which 
together): 
Standalone
Metropolis Healthcare Limited
70
II. Products/Services
II-14. Details of business activities (accounting for 90% of the turnover):
II-15. Products/Services sold by the entity (accounting for 90% of the entity’s turnover):
III. Operations
Sr.  
No.
% of Total Turnover 
contributed
98.43%
1
NIC Code
Product/Service
Diagnostic Services in the area of 
Pathology
86905
Not Applicable to us, 
as the company offers 
diagnostic testing 
services in the area of 
Pathology.
National
International
Location
Number of Plants
156
156
19
19
Total
III-17. Markets served by the entity: 
a. 
Number of locations
Locations
Number
National  
(No. of States)
20
Locations
Number
International 
(No. of 
Countries)
9*
 
*Internal Markets served - 5 (with operations) & 4 (B2B); Total - 9
b. 
What is the contribution of exports as a percentage of the total turnover of the entity?
 
NA
c. 
A brief on types of customers
 
 The Company’s customers include B2B and B2C customers, hospital lab management, corporate clients, and Government 
clients.
Sr.  
No.
% of Turnover of the 
entity
98.43%
1
Description of business activity
Description of main activity
Human Health and Social Work 
Activities
Diagnostic Testing Service Provider and 
Clinical Trials Research Services.
Statutory 
Reports
Annual Report 2022-23
71
IV. Employees
IV-18. Details as at the end of Financial Year:  
a.
Employees and workers (including differently abled):
Sr.
No
Particulars
Total
(A)
Male
Female
No(B)
%(B/A)
No(C)
%(C/A)
   Employees
1.
Permanent (D)
2,156
1,483
68.8%
673
31.2%
2.
Other than Permanent (E)
265
121
45.7%
144
54.3%
3.
Total Employees (D + E)
2,421
1,604
66.3%
817
33.7%
   Workers
4.
Permanent (F)
2,144
1,039
48.5%
1,105
51.5%
5.
Other than Permanent (G)
200
124
62.0%
76
38.0%
6.
Total Workers (F + G)
2,344
1,163
49.6%
1,181
50.4%
IV-18. Details as at the end of Financial Year: 
b.
Differently-abled Employees and Workers:
Sr.
No
Particulars
Total
(A)
Male
Female
No(B)
%(B/A)
No(C)
%(C/A)
   Differently-Abled Employees
1.
Permanent (D)
0
0
0
0
0
2.
Other than Permanent (E)
0
0
0
0
0
3.
Total Differently-Abled 
Employees (D + E)
0
0
0
0
0
   Differently-Abled Workers
4.
Permanent (F)
0
0
0
0
0
5.
Other than Permanent (G)
0
0
0
0
0
6.
Total Workers (F + G)
0
0
0
0
0
IV-19. Participation/Inclusion/Representation of Women:
No. and percentage of Females
No(B)
Total
(A)
Particulars
%(B/A)
7
2
28.57%
Board of Directors
4
1
25.00%
Key Management 
Personnel
Metropolis Healthcare Limited
72
IV-20. Turnover rate for permanent employees and workers. (Disclose trends for the past 3 years):
(Turnover rate in 
current FY 2022-23)
(Turnover rate in 
previous FY 2021-22)
(Turnover rate in the year prior 
to the previous FY 2020-21)
Male
Female
Total
Male
Female
Total
Male
Female
Total
17%
9%
14%
28%
22%
26%
25%
20%
24%
13%
13%
13%
24%
22%
23%
25%
28%
26%
Permanent Employees
Permanent Workers
V. Holding, Subsidiary and Associate Companies (including joint ventures)
V-21. (a) Names of holding/subsidiary/associate companies/joint ventures.
Sr. 
No.
Name of the holding / subsidiary 
/ associate companies / joint 
ventures (A)
Indicate whether 
holding/subsidiary/ 
associate/ joint 
venture
% of shares 
held by listed 
entity
Does the entity indicated at column 
A, participate in the Business 
Responsibility initiatives of the listed 
entity? (Yes/No)
1
Amin's Pathology Laboratory 
Private Limited
Subsidiary
100%
No
2
Centralab Healthcare Services 
Private Limited
Subsidiary
100%
No
3
Ekopath Metropolis Lab Services 
Private Limited
Subsidiary
60%
No
4
Metropolis Histoxpert Digital 
Services Private Limited
Subsidiary
100%
No
5
Metropolis Healthcare (Mauritius) 
Limited
Subsidiary
100%
No
6
Metropolis Bramser Lab Services 
(Mtius) Limited
Subsidiary
100%
No
7
Metropolis Star Lab Kenya Limited
Subsidiary
100%
No
8
Metropolis Healthcare Ghana 
Limited
Subsidiary
100%
No
9
Metropolis Healthcare Lanka 
Private Limited (Formerly 
known as Nawaloka Metropolis 
Laboratories Private Limited)
Subsidiary
100%
No
10
Metropolis Healthcare (Tanzania) 
Limited
Subsidiary
99.99%
No
11
Metropolis Healthcare Uganda 
Limited
Subsidiary
100%
No
VI. CSR Details
VI-22. (i). Whether CSR is applicable as per section 135 of Companies Act, 2013: (Yes/No)
Yes
VI-22. (ii). Turnover (in Rs.): Rs. 1,06,604 Lakhs
VI-22. (iii). Net worth (in Rs.): Rs. 93,601 Lakhs
Statutory 
Reports
Annual Report 2022-23
73
VII. Transparency and Disclosures Compliances
VII-23. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible 
Business Conduct:
Stakeholder 
group from 
whom 
complaint is 
received
Grievance redressal 
mechanism in place 
(yes/no) (if yes, then 
provide web-link for 
grievance redressal 
policy)
FY 2022-23
 FY 2021-22
Number of 
complaints 
the year
 Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Number of 
complaints 
the year
Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Communities
No
community.
Investors 
(other than 
Shareholders)
Yes. Investors can 
mentioned in the link 
below: https://www.
metropolisindia.com/
investors.
1
0
0
0
Shareholders
Yes. For any grievances, 
Shareholders can reach 
out to Compliance 
on Tel: +91-22-6258 
2810 or write an 
email to: secretarial@
metropolisindia.com
/ investors.relations@
metropolisindia.com 
1
0
0
0
Employees 
and Workers
Yes. The Company 
Internal Grievance 
Redressal Policy in 
place.
15
2*
12
0
Customers
No. The Company 
does not have a 
formal Grievance 
Redressal Policy. 
However, there is a 
dedicated customer 
service number (+91 
8422 801 801) and 
email id: support@
metropolisindia.com 
that address and 
handle all consumer 
complaints. In addition, 
the Company responds 
to customer concerns 
which its receives 
social media handles.
16,181
08
Complaints 
will be 
closed 
after RCA 
(Root 
Cause 
Analysis)/ 
CAPA 
(Corrective 
Action and 
Preventive 
Action) 
22,121
0
All 
complaints 
resolved
Metropolis Healthcare Limited
74
Stakeholder 
group from 
whom 
complaint is 
received
Grievance redressal 
mechanism in place 
(yes/no) (if yes, then 
provide web-link for 
grievance redressal 
policy)
FY 2022-23
 FY 2021-22
Number of 
complaints 
the year
 Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Number of 
complaints 
the year
Number of 
complaints 
pending 
resolution at 
close of the 
year
Remarks
Value Chain 
partners 
No
There were no complaints/grievances received from the Value Chain partners except 
resolved.
Other (please 
specify)
*The unresolved complaints pertaining to FY 2022-23 to be closed during FY 2023-24.
VII-24. Overview of the entity’s material responsible business conduct issues. Please indicate material responsible business 
conduct and sustainability issues pertaining to environmental and social matters that present a risk or an opportunity to your 
per the following format:
Sr. 
No.
Material issue 
Indicate 
whether 
risk or 
opportunity 
(R/O)
Rationale for 
identifying the risk 
/ opportunity
In case of risk, approach to 
adapt or mitigate
Financial implications of 
the risk or opportunity 
(Indicate positive or 
negative implications)
1.
Energy 
Management
Opportunity
Energy intensive 
operations
The Company has a detailed 
phase-wise energy reduction 
plan with concrete milestones.
If this aspect is taken 
care of, it will result in a 
reduction in emissions 
and the Company can 
charge a premium/
attract GenZ and GenY 
customers.
2.
Waste 
Management
Risk
Generation of 
Biomedical Waste 
due to nature of 
business
Disposal is done through a 
Government authorized partner 
and the waste is segregated 
into different color bags with 
barcodes. It is weighed before 
being handed over to an 
authorized vendor. All safety 
norms are followed from 
generation until handover to 
Authority.
If not disposed of 
properly, it could lead to 
the spread of diseases 
and affect the social 
license to operate.
3
Employee Health 
& Safety
Risk
Sample Collection
The Company has a robust 
selection, induction and training 
program for the concerned 
staff.
Revenue loss, recruitment 
challenges.
4
Diversity, Equity 
and Inclusion
Opportunity
Good Governance 
Practice
43% of the workforce of the 
Company is female
The Company has also 
launched a program that aims 
to help women who are looking 
to restart their careers. 
Goodwill in market, a 
motivated workforce 
and a positive working 
environment. 
Statutory 
Reports
Annual Report 2022-23
75
Policy and Management Processes
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
1.
a.
Whether your entity’s policy/policies 
cover each principle and its core 
elements of the NGRBCs. (Yes/No)
Yes
1.
b.
Has the policy been approved by the 
Board? (Yes/No)
Yes
1.
c. 
Web Link of the Policies, if available
https://www.metropolisindia.com/newdata/Investors/code-of-conduct/
MHL_Business-Responsibility-policy.pdf
2.
Whether the entity has translated the policy 
into procedures. (Yes / No)
Yes
3.
Do the enlisted policies extend to your value 
chain partners? (Yes/No)
No
4.
Name of the national and international 
(e.g. Forest Stewardship Council, Fairtrade, 
Rainforest Alliance, Trustee) standards (e.g. 
SA 8000, OHSAS, ISO, BIS) adopted by your 
entity and mapped to each principle.
None
5.
As a responsible organization, the Company is committed to following 
the nine principles and its core elements of the NGRBCs. The Company 
will be focusing on and implementing various initiatives in the areas 
of Energy Conservation, Water and Waste Management, Improving 
the Diversity/New Hire Ratio, Strengthening Women Leadership 
Employees, and Fostering Diverse and Accountable Governance through 
collaboration with external consultants. The company is in the process of 
6.
Performance of the entity against the 
along-with reasons in case the same are not 
met.
The Company will continue to monitor its performance against each 
goals and targets and will take appropriate action as needed.
Governance, leadership and oversight
7.
Statement by director responsible for the 
business responsibility report, highlighting 
ESG related challenges, targets and 
regarding the placement of this disclosure)
Over the years, Metropolis has laid unrivalled emphasis on sustainability. 
Our Company has always kept pace with the changing times, actively 
adopting the best of available technologies, processes, and policies 
constantly  optimize the quality and scale of our operations, while 
minimizing resource consumption and the impact on the environment.
On the community front, our Company has always been at the forefront 
of conducting impactful camps and driving numerous workshops around 
healthcare subjects for different sections of society. At Metropolis, we 
have partnered with societies, corporate groups, educational institutions, 
Government bodies, NGOs, wellness foundations and a host of other 
organizations to make a difference in the lives of people. In line with the 
UN Sustainable Development Goals, (i.e., SDG 3,4,5), our CSR initiatives 
are aimed at imparting education, creating awareness on Gender, 
Equality, Health, and Women’s Empowerment.
SECTIONB-MANAGEMENT AND PROCESS DISCLOSURES
Metropolis Healthcare Limited
76
Disclosure Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
The core teams of Metropolis across Corporate functions ensure 
that operations are sustainable in every aspect. The teams have 
been addressing key issues such as proper handling and disposal of 
biomedical waste, switching to biodegradable bags in place of plastic 
bags, water conservation, energy management, employee health 
materiality assessment exercise on some key ESG topics that might 
impact our business. This assessment was conducted digitally on the 
GovEVA platform to understand the company’s readiness vis-a-vis global 
standards. The matrix for the materiality was developed on the basis of 
the frameworks of GRI, SASB, and SDG.
At Metropolis, we believe this analysis will help us in allocating 
resources effectively and implementing various initiatives under ESG 
that will enable us in making a larger impact and long-term value 
for stakeholders. We will continue to monitor and improve our ESG 
performance year-on-year. Furthermore, we remain dedicated to 
responsibilities as one of the country’s leading pathologists.
8.
Details of the highest authority responsible 
for implementation and oversight of the 
Business Responsibility policy (ies).
Managing Director
9. 
of the Board/ Director responsible for 
decision making on sustainability related 
issues? (Yes / No). If yes, provide details.
No
10.  Details of Review of NGRBCs by the Company: Indicate whether review was undertaken by Director / Committee of the 
Board/ Any other Committee:
Subject for Review
Indicate whether review was undertaken by 
Director / Committee of the Board/ Any Other 
Committee
Frequency (Annually/ Half-yearly/ Quarterly/ 
Any Other – Please Specify)
P1
P2
P3
P4
P5
P6
P7
P8
P9
P1
P2
P3
P4
P5
P6
P7
P8
P9
Performance against 
above policies and follow 
up action
No
Compliance with 
statutory requirements 
of relevance to the 
principles, and, 
compliances
No
11. Has the entity carried out independent assessment/ evaluation of the working of its policies by an external agency? (Yes/
No). If yes, provide name of the agency:
Sr. no
P1
P2
P3
P4
P5
P6
P7
P8
P9
No
Statutory 
Reports
Annual Report 2022-23
77
12. If answer to question (1) above is No i.e. not all Principles are covered by a policy, reasons to be stated:
Questions
P1
P2
P3
P4
P5
P6
P7
P8
P9
The entity does not consider the Principles material to its business 
(Yes/No)
 -
The entity is not at a stage where it is in a position to formulate and 
 -
available for the task (Yes/No)
-
-
Any other reason (please specify)
-
SECTION C: PRINCIPLE WISE PERFORMANCE DISCLOSURE
PRINCIPLE 1 
Businesses should conduct and govern themselves with integrity, and in a manner that is Ethical, Transparent and 
Accountable.
Essential Indicators
Segment
Total 
number of 
training and 
awareness 
programs 
held
Topics/Principles covered under the training 
and its impact
Percentage 
of persons 
in respective 
category covered 
by the awareness 
programs
Board of Directors
4
100%
Key Managerial 
personnel
1
projects
25%
Employees other than 
BoD and KMPs
20
doctors to build functional knowledge. 
of I’ sessions was built around Self Awareness, 
Leadership, Business Communication & People 
Management. These sessions were a great opportunity 
for professional development and growth. It’s always 
can help advance one’s career or business. 
taking ownership, people leadership, and business 
communication which were particularly helpful in 
providing participants with practical tips and strategies 
for improving in these areas. It’s important for 
individuals to learn how to take ownership of their work 
and responsibilities, as well as to effectively lead and 
communicate with others. 
48%
Workers
2
    One functional program was conducted as part of 
conducted
100%
Metropolis Healthcare Limited
78
(Listing Obligations and Disclosure Obligations) Regulations, 2015 and as disclosed on the entity’s website)
Category
NGRBC 
Principle
Name of the Regulatory/ 
Enforcement Agencies/ 
Judicial Institutions
Amount 
(In Rs.)
Brief of the 
Case
Has an appeal been 
preferred? (Yes/No)
Penalty/ Fine
-
-
-
-
-
Settlement
-
-
-
-
-
Compounding fee
-
-
-
-
-
Non-Monetary
Category
NGRBC Principle
Name of the Regulatory/ Enforcement 
Agencies/Judicial Institutions
Brief of the 
Case
Has an appeal been 
preferred? (Yes/No)
Imprisonment
-
-
-
-
Punishment
-
-
-
-
Monetary
EI-3. Of the instances disclosed in Question 2 above, details of the Appeal/ Revision preferred in cases where monetary or 
non-monetary action has been appealed:
Sr. No.
Case Details
Name of the Regulatory/Enforcement Agencies/Judicial Institutions
1
-
-
EI-4. Does the entity have an anti-corruption or anti-bribery policy? If yes, provide details in brief and if available, provide a 
web link to the policy:
No
EI-5. Number of Directors/KMPs/employees/workers against whom disciplinary action was taken by any law enforcement 
agency for the charges of bribery/ corruption:
Category
(Current Financial Year)
(Previous Financial Year)
0
0
0
0
0
0
0
0
Directors
Employees
KMPs
Workers
Remark: There were no such cases. However, this information solely applies to Metropolis Healthcare operations.
Statutory 
Reports
Annual Report 2022-23
79
Category
Number 
(CY)
Remarks 
(CY)
Number 
(PY)
Remarks 
(PY)
Number of Complaints Received in Relation to 
0
-
0
-
Number of Complaints Received in Relation to 
0
-
0
-
Leadership Indicators
Total number of awareness 
programs held
-
-
Topics / Principles covered 
under the training
-
% of Value Chain Partners covered (by value of 
business done with such partners) under the 
awareness programs
No) If Yes, provide details of the same. -
Yes, the company has a Code of Conduct for its Board Members and the Leadership Team that outlines the guidelines to prevent 
PRINCIPLE 2 
Businesses should provide goods and services in a manner that is sustainable and safe
Essential Indicators
and social impacts of product and processes to total R&D and capex investments made by the entity, respectively:
R&D
CAPEX
-
-
-
16,00,000
-
Current Financial 
Year
Previous Financial 
Year
Previous Financial 
Year
Current Financial 
Year
Details of Improvements in Environmental 
and Social Impacts
Metropolis Healthcare Limited
80
EI-2. a. Does the entity have procedures in place for sustainable sourcing? (Yes/No)
The company has been partnering with suppliers who adhere to environmentally and socially responsible practices. At Metropolis, 
we prefer doing business with ethical local suppliers who share our goals to reduce the adverse impact on the local community, 
the environment, and natural resources while protecting public health and safety. The business is currently developing a process 
for sustainable sourcing and will undertake various initiatives related to the same.
EI-2.b. If yes, what percentage of inputs were sourced sustainably?  
NA
EI-3. Describe the processes in place to safely reclaim your products for reusing, recycling and disposing at the end of life, 
for (a) Plastics (including packaging) (b) E-waste (c) Hazardous waste and (d) other waste 
NA 
EI-4. Whether Extended Producer Responsibility (EPR) is applicable to the entity’s activities (Yes / No). If yes, whether the 
waste collection plan is in line with the Extended Producer Responsibility (EPR) plan submitted to Pollution Control Boards? 
If not, provide steps taken to address the same
NA
Leadership Indicators
LI-1. Has the entity conducted Life Cycle Perspective / Assessments (LCA) for any of its products (for manufacturing industry) 
or for its services (for service industry)? If yes, provide details in the following format?
Sr. 
No.
NIC 
Code
Name of 
Product /
Service
% of Total 
Turnover 
contributed
Boundary for which the 
Life Cycle Perspective 
/ Assessment was 
conducted
Whether conducted 
by independent 
external agency 
(Yes/No)
Results communicated in 
public domain (Yes/No) If 
yes, provide the web-link.
1
Not Applicable
describe the same along-with action taken to mitigate the same.
Name of Product / 
Service
Description of the 
Risk / Concern
Action Taken
Testing 
harmful microorganisms that can infect hospital 
patients, health workers and the general public
Disposal through Govt authorized 
partner 
Calibration
Accuracy in results 
Calibrated yearly once as per NABL 
norms
Testing 
If the sewage is discharged without being treated 
into the lakes, rivers or grounds, it will contaminate 
the freshwater sources. Drinking this contaminated 
Wastewater disposed of after ETP
Statutory 
Reports
Annual Report 2022-23
81
LI-3. Percentage of recycled or reused input material to total material (by value) used in production (for manufacturing 
industry) or providing services (for service industry).
Indicate Input Material
Recycled or Re-used Input Material to Total Material
FY 2022-23
FY 2021-22
No Recycling /reused process
NA
NA
LI-4. Of the products and packaging reclaimed at end of life of products, amount (in metric tons) reused, recycled, and safely 
disposed, as per the following format: 
FY 2022-23
FY 2021-22
Re-Used
Recycled
Safely Disposed
Re-Used
Recycled
Safely Disposed
Plastics (including Packaging)
NA
NA
NA
NA
NA
NA
E-Waste
NA
NA
NA
NA
NA
NA
Hazardous Waste
NA
NA
NA
NA
NA
NA
Other Waste
NA
NA
NA
NA
NA
NA
LI-5. Reclaimed products and their packaging materials (as percentage of products sold) for each product category:
Sr. 
No. 
Indicate Product Category
Reclaimed Products and their Packaging Materials as % of 
Total Products sold in respective category
1
-
-
Metropolis Healthcare Limited
82
PRINCIPLE 3
Businesses should respect and promote the well-being of all employees, including those in their value chains
Essential Indicators
EI-1.a. Details of measures for the well-being of employees (Permanent Employees).
Category
% of Employees covered by
Total 
(A)
Health Insurance
Accident Insurance
Day Care Facilities
Number 
(B)
% (B/A)
Number 
(C)
% (C/A)
Number 
(D)
% (D/A)
Number 
(E)
%  
(E/A)
Number 
(F)
% (F/A)
    Permanent Employees
Male
1,483
1,483
100%
1,483
100%
-
-
69
5%
-
-
Female
673
673
100%
673
100%
38
6%
-
-
-
-
Total
2,156
2,156
100%
2,156
100%
38
6%
69
5%
-
-
   Other than Permanent Employees
Male
121
9
7.4%
121
100%
-
-
1
1%
-
-
Female
144
9
6.3%
141
100%
0
0%
-
-
-
-
Total
265
18
7%
265
100%
0
0%
1
1%
-
-
EI-1. b. Details of measures for the well-being of workers. (Permanent Workers).
Category
% of Employees covered by
Total 
(A)
Health Insurance
Accident Insurance
Day Care Facilities
Number 
(B)
% (B/A)
Number 
(C)
% (C/A)
Number 
(D)
% (D/A)
Number 
(E)
% (E/A)
Number 
(F)
% (F/A)
    Permanent Workers
Male
1,039
1,039
100%
1,039
100%
-
-
23
2.2%
--
--
Female
1,105
1,105
100%
1,105
100%
19
1.70%
--
--
--
--
Total
2,144
2,144
100%
2,144
100%
19
1.70%
23
2.2%
--
--
Statutory 
Reports
Annual Report 2022-23
83
Category
% of Employees covered by
Total 
(A)
Health Insurance
Accident Insurance
Day Care Facilities
Number 
(B)
% (B/A)
Number 
(C)
% (C/A)
Number 
(D)
% (D/A)
Number 
(E)
% (E/A)
Number 
(F)
% (F/A)
  Other than Permanent Workers
Male
124
124
100%
124
100%
-
-
1
0.81%
-
-
Female
76
76
100%
76
100%
3
3.90%
-
-
-
-
Total
200
200
100%
200
100%
3
3.90%
1
0.81%
-
-
Remarks: Employees are covered under Group Mediclaim Insurance or ESIC
No. of 
employees 
covered as 
a % of total 
employees. 
(CY)
No. of 
workers 
covered as 
a % of total 
workers. 
(CY)
Deducted 
and 
deposited 
with the 
authority 
(Y/N/N.A.). 
(CY)
No. of 
employees 
covered as 
a % of total 
employees. 
(PY)
No. of 
workers 
covered as 
a % of total 
workers. 
(PY)
Deducted 
and 
deposited 
with the 
authority 
(Y/N/N.A.). 
(PY)
PF
88.82%
100%
Y
90.46%
100%
Y
Gratuity
89.48%
100%
Y
91.11%
100%
Y
ESI
0%
100%
Y
0%
100%
Y
Others – Please Specify
-
-
-
-
-
-
Remarks: Data consists of consultants for whom PF, Gratuity or ESIC isn’t applicable.
of the Rights of Persons with Disabilities Act, 2016? If not, whether any steps are being taken by the entity in this regard:
to differently-abled people.
EI-4. Does the entity have an equal opportunity policy as per the Rights of Persons with Disabilities Act, 2016? If so, provide 
a web-link to the policy:
The Company is in the process of developing the policy and has processes in place to ensure equal opportunity. 
Metropolis Healthcare Limited
84
EI-5. Return to work and Retention rates of permanent employees and workers that took parental leave:
Permanent 
Employees
Permanent 
Workers
72%
100% 
100%
69%
Male
83%
91%
100%
76%
Female
74%
98%
100%
72%
Total
Return to 
Work Rate
EI-6. Is there a mechanism available to receive and redress grievances for the following categories of employees and worker? 
If yes, give details of the mechanism in brief:
Other than Permanent 
Employees
Permanent Employees
Other than Permanent 
Workers
Permanent Workers
Yes, the Company uses HRMS Software 
that helps and guides the employees to 
raise their concerns, which are resolved 
by the teams assigned to address the 
grievances.
Yes/No (If Yes, then give details 
of the mechanism in brief)
Category
Gender
Retention 
Rate
Return to 
Work Rate
Retention 
Rate
Statutory 
Reports
Annual Report 2022-23
85
EI-7. Membership of employees and worker in association(s) or Unions recognized by the listed entity:
Category
FY 2022-23
FY 2021-22
Total 
employees 
/ workers in 
respective 
category (A)
No. of employees / 
workers in respective 
category, who are part 
of Association(s) or 
Union(B)
% (B/A)
Total 
employees 
/ workers in 
respective 
category (C)
No. of employees / 
workers in respective 
category, who are part 
of Association(s)or 
Union(D)
%(D/C)
Total 
Permanent 
Employees 
-
-
-
-
-
-
Male
-
-
-
-
-
-
Female
-
-
-
-
-
-
Total 
Permanent 
Workers
-
-
-
-
-
-
Male
-
-
-
-
-
-
Female
-
-
-
-
-
-
EI-8. Details of training given to employees and workers:
Category
FY 2022-23
FY 2021-22
Total 
(A)
On Health and 
Safety measures
On Skill 
upgradation
Total 
(D)
On Health and 
Safety measures
On Skill 
upgradation
No. (B)
%(B/A)
No. (C)
%(C/A)
No. (E)
%(E/D)
No. (F)
%(F/D)
   Employees
Male
1,604
39
2%
416
26%
1,212
211
17%
467
39%
Female
817
35
4%
261
32%
483
154
32%
149
31%
Total
2,421
74
3%
677
28%
1,695
365
22%
616
36%
Metropolis Healthcare Limited
86
Category
FY 2022-23
FY 2021-22
Total 
(A)
On Health and 
Safety measures
On Skill 
upgradation
Total 
(D)
On Health and 
Safety measures
On Skill 
upgradation
No. (B)
%(B/A)
No. (C)
%(C/A)
No. (E)
%(E/D)
No. (F)
%(F/D)
   Workers
Male
1,163
30
3%
101
9%
844
117
14%
32
4%
Female
1,181
34
3%
126
11%
684
106
15%
122
18%
Total
2,344
64
3%
227
10%
1,528
223
15%
154
10%
EI-9. Details of performance and career development reviews of employees and workers:
Category
FY 2022-23
FY 2021-22
Total (A)
No. (B)
% (B/A)
Total (C)
No. (D)
% (D/C)
   Employees
Male
1,607
1,403
87%
1,607
967
60%
Female
818
698
85%
818
449
55%
Total
2,425
2,101
87%
2,425
1,416
58%
   Workers
Male
1,160
1,010
87%
1,160
526
45%
Female
1,180
988
84%
1,180
432
37%
Total
2,340
1,998
85%
2,340
958
41%
Statutory 
Reports
Annual Report 2022-23
87
The Company did not have any process in place 
during FY 2022-23 to capture the data. However, 
it has implemented an occupational health and 
safety management system with effect from 
April 2023, wherein a provision for capturing all 
occurrences in the system has been created. 
This will allow the monthly tabulation of data, as 
EI-10. a. Whether an occupational health 
and safety management system has been 
implemented by the entity? (Yes/ No). If yes, 
the coverage such system?: 
Yes. The Mediclaim coverage is extended to 
all employees/workers, either through Group 
Mediclaim or ESIC, whichever is applicable. 
EI-10. d. Do the employees/ worker of the 
entity have access to non-occupational 
medical and healthcare services? (Yes/ No): 
We provide documentation mechanism for 
reporting safety incidents. 
EI-10. c. Whether you have processes for 
workers to report the work related hazards 
and to remove themselves from such risks. 
(Y/N): 
EI-10. b. What are the processes used to 
identify work-related hazards and assess 
risks on a routine and non-routine basis by 
the entity? - 
In accordance with the recommended 
various workplace hazards that could arise 
and have developed the required policies and 
guidelines to address them. Additionally, the 
organization has put out a risk assessment and 
mitigation plan. In order to ensure compliance, 
our in-house Quality Control department 
conducts regular audits.
Metropolis Healthcare Limited
88
EI-11. Details of safety related incidents, in the following format:
Safety Incident/Number
Category
FY 2022-23
FY 2021-22
Lost Time Injury Frequency Rate 
(LTIFR)  
(per one million-person hours worked)
   
Employees
-
-
 
Workers
-
-
Total recordable work-related injuries
   
Employees
-
-
 
Workers
-
-
No. of fatalities
   
Employees
-
-
 
Workers
-
-
High consequence work-related injury 
or ill-health (excluding fatalities)
   
Employees
-
-
 
Workers
-
-
EI-12. Describe the measures taken by the 
entity to ensure a safe and healthy work 
place: 
The Company has designed its labs and 
related-infrastructure which ensure that 
safety is inbuilt into the processes as per the 
area is segregated from the lab area and 
all labs are treated as restricted entry. The 
employees follow standard safety precautions 
while processing samples. The administration 
checks are done periodically. 
Statutory 
Reports
Annual Report 2022-23
89
EI-13. Number of complaints on the following made by employees and workers:
FY 2022-23
FY 2021-22
Filed during 
the year
Pending 
resolution at 
the end of year
Remarks
Filed during 
the year
Pending 
resolution at 
the end of year
Remarks
Working Conditions
-
-
-
-
-
-
Health & Safety
-
-
-
-
-
-
EI-14. Assessments for the year:
Health and Safety Practices
-
Working Conditions
-
(by entity or statutory authorities or third-parties)
Category
risks / concerns arising from assessments of health & safety practices and working conditions:
NA
LI-1. Does the entity extend any life insurance or any compensatory package in the event of death of (A) Employees (Y/N) 
(B) Workers (Y/N): 
No. Only in case of accidental death, immediate family/nominees of employee gets compensatory package. 
Leadership Indicators
LI-2. Provide the measures undertaken by 
the entity to ensure that statutory dues have 
been deducted and deposited by the value 
chain partners:
As a responsible organization, post-salary 
disbursement, the Company initiates 
validates the same, well before the due date 
to ensure compliance.
Metropolis Healthcare Limited
90
Health and Safety Practices
Working Conditions
-
% of value chain partners (by value of business done 
with such partners) that were assessed
Category
assessments of health and safety practices and working conditions of value chain partners.
NA
LI-3. Provide the number of employees / workers having suffered high consequence work-related injury / ill-health / fatalities 
(as reported in Q.11 of Essential Indicators above), who have been are rehabilitated and placed in suitable employment or 
whose family members have been placed in suitable employment:
Total no. of affected employees/ workers
No. of employees/workers that are rehabilitated 
and placed in suitable employment or whose 
family members have been placed in suitable 
employment
FY 2022-23
FY 2021-22
FY 2022-23
FY 2021-22
Employees
-
-
-
-
Workers
-
-
-
-
LI-4. Does the entity provide transition assistance programs to facilitate continued employability and the management of 
career endings resulting from retirement or termination of employment? (Yes/ No):
Transitional training in the Company is all about equipping employees with necessary skills and knowledge to move through 
transition. Examples include promotion, change of team or cross-functional within the organization.
LI-5. Details on assessment of value chain partners:
Statutory 
Reports
Annual Report 2022-23
91
PRINCIPLE 4
Businesses should respect the interests of and be responsive to all its stakeholders
Essential Indicators
LI-1. Provide the processes for consultation between stakeholders and the Board on economic, environmental, and social 
topics or if consultation is delegated, how is feedback from such consultations provided to the Board: 
Respective executives take care of the same and provide periodical updates to the Board by the CEO/MD.
Leadership Indicators
Yes. The Company has done a detailed digital 
materiality assessment where the various 
stakeholders were polled through the double 
materiality approach and incorporated ESG 
strategies. The double materiality was conducted 
with the help of an external ESG consultant 
and multiple workshops were organized with 
the various stakeholders. The results of the 
assessment have been incorporated into the 
Company’s ESG strategies.
LI-2.Whether stakeholder consultation is used 
of environmental, and social topics (Yes / 
No). If so, provide details of instances as to 
how the inputs received from stakeholders on 
these topics were incorporated into policies 
and activities of the entity: 
EI-1. Describe the processes for identifying key stakeholder groups of the entity: 
The Company has undertaken a rigorous process to periodically identify and engage with internal and external stakeholders. It 
also takes the help of a professional ESG consultant for the same.
Sr. 
No.
Stakeholder 
Group
Whether 
Vulnerable & 
Marginalized 
Group (Yes/
No)
Channels of 
Communication (Email, 
SMS, Newspaper, 
Pamphlets, Advertisement, 
Community Meetings, 
Notice Board, Website), 
Other
Frequency of 
Engagement 
(Annually/ 
Half Yearly/ 
Quarterly / 
Others – Please 
Specify)
Purpose and scope of 
engagement including key 
topics and concerns raised 
during such engagement
1
Employees
No
Emails, Surveys, Appraisals
Quarterly
Regular Company Updates / 
Training Needs
2
Franchised lab 
Partners
No
Emails, Surveys
Monthly
Promotional Schemes, 
Training Updates
3
Customers
No
Surveys, others
Monthly
Promotional Schemes, New 
Tests
4
Govt/Regulators
No
Email, Website
Quarterly, Half 
Yearly and 
Annually
Representations / Perspective 
on Change in Regulations / 
Upcoming Laws
5
Investors/
Shareholders
No
Email, Newspaper, Notice, 
Website
Quarterly, Half 
Yearly and 
annually
Financial Results / other 
Corporate Announcements
Metropolis Healthcare Limited
92
LI-3. Provide details of instances of engagement with, and actions taken to, address the concerns of vulnerable/ marginalized 
stakeholder groups:
The Company is in the process of identifying vulnerable/marginalized stakeholders groups and developing an engagement plan.
PRINCIPLE 5
Businesses should respect and promote human rights
Essential Indicators
EI-1. Employees and workers who have been provided training on human rights issues and policy(ies) of the entity, in the 
following format:
Category
 FY 2022-23
 FY 2021-22
Total (A)
No. of 
employees 
/ workers 
covered (B)
%(B/A)
Total (C)
No. of 
employees 
/ workers 
covered (D)
%(D/C)
    Employees
Permanent
2,350
1,626
69%
2,170
1,646
76%
Other than 
Permanent
322
208
65%
368
190
52%
Total Employees
2,672
1,834
69%
2,538
1,836
72%
    Workers
Permanent
2,091
1,531
73%
1,695
1,449
85%
Other than 
Permanent
548
431
79%
255
169
66%
Total Workers
2,639
1,962
74%
1,950
1,618
83%
Statutory 
Reports
Annual Report 2022-23
93
EI-2. Details of minimum wages paid to employees, in the following format:
Category
FY 2022-23
FY 2021-22
Total 
(A)
Equal to 
Minimum Wage
More than 
Minimum Wage
Total 
(D)
Equal to Minimum 
Wage
More than 
Minimum Wage
No. (B)
% (B/A)
No. (C)
% (C/A)
No.(E)
% (E /D)
No.(F)
% (F/D)
 Employees
   Permanent
Male
1,483
0
0%
1,483
100%
1,138
0
0%
1,138
100%
Female
673
0
0%
673
100%
398
0
0%
398
100%
    Other than Permanent
Male
121
0
0%
121
100%
77
0
0%
77
100%
Female
144
0
0%
144
100%
85
0
0%
85
100%
Workers
   Permanent
Male
1,039
1,039
100%
0
0%
733
733
100%
0
0%
Female
1,105
1,105
100%
0
0%
636
636
100%
0
0%
   Other than Permanent
Male
124
124
100%
0
0%
108
108
100%
0
0%
Female
76
76
100%
0
0%
48
48
100%
0
0%
Metropolis Healthcare Limited
94
EI-3. Details of remuneration/salary/wages, in the following format:
Male
Female
Number
Median 
Remuneration/ 
Salary/Wages of 
respective category
Number
Median 
Remuneration/ 
Salary/Wages of 
respective category
Board of Directors (BoD)
5
--
2
--
Key Managerial Personnel
3
1,80,00,000
1
5,00,00,000
Employees other than 
BoD and KMP
1,601
4,60,140
842
4,14,396
Workers
1,163
2,33,904
1,181
2,35,776
EI-4. Do you have a focal point (Individual/ Committee) responsible for addressing human rights impacts or issues caused or 
contributed to by the business? (Yes/No)-
No
EI-5. Describe the internal mechanisms in place to redress grievances related to human rights issues:
No
EI-6. Number of Complaints on the following made by employees and workers:
FY 2022-23
FY 2021-22
Filed during 
the year
Pending 
resolution 
at the end 
of year
Remarks
Filed 
during the 
year
Pending 
resolution 
at the end 
of year
Remarks
Sexual Harassment
 2
 1
NIL
 0
 0
NIL
Discrimination at Workplace
 0
 0
NIL
 0
 0
NIL
Child Labour
 0
 0
NIL
 0
 0
NIL
Statutory 
Reports
Annual Report 2022-23
95
FY 2022-23
FY 2021-22
Filed during 
the year
Pending 
resolution 
at the end 
of year
Remarks
Filed 
during the 
year
Pending 
resolution 
at the end 
of year
Remarks
Forced Labour/Involuntary 
Labour
 0
 0
NIL
 0
 0
 NIL
Wages
 0
 0
 NIL
 0
 0
 NIL
Other Human 
Rights-Related Issues
 0
 0
 NIL
 0
 0
 NIL
EI-7. Mechanisms to prevent adverse consequences to the complainant in discrimination and harassment cases:
We have a dedicated Prevention of Sexual Harassment (POSH) committee in place to address all such complaints. As a process, 
we treat these complaints in a discreet manner and take necessary corrective actions accordingly.
EI-8. Do human rights requirements form part of your business agreements and contracts? (Yes/No):
Yes
EI-9. Assessments for the year:
Category
authorities or third-parties)
Child Labor
-
Forced/Involuntary Labor
-
Sexual Harassment
-
Discrimination at Workplace
-
Wages
-
Others – Please Specify
-
2023-24 and put processes in place.
Metropolis Healthcare Limited
96
assessments at Question 9 above:
NA
Leadership Indicators
No
Persons with Disabilities Act, 2016?
Yes. Few of the Company’s diagnostic centres have the required infrastructure to make it accessible to differently-abled patients. 
The company is working on to make gradual improvements in all the centres. Additionally, the company also offers home 
collection services to customers who are unable to travel to the centre owing to a disability or other medical issues.
LI-4. Details on assessment of value chain partners:
Category
% of value chain partners 
(by value of business done with such partners) that were assessed
Sexual Harassment
-
Discrimination at Workplace
-
Child Labour
-
Forced Labour/Involuntary Labour
-
Wages
-
Others – please specify
-
LI-2. Details of the scope and coverage of 
any Human rights due-diligence conducted: 
No
Statutory 
Reports
Annual Report 2022-23
97
assessments at Question 4 above:
NA
PRINCIPLE 6
Businesses should respect and make efforts to protect and restore the environment
Essential Indicators
EI-1. Details of total energy consumption (in Joules or multiples) and energy intensity.
(GJ)
Parameter
FY 2022-23
FY 2021-22
Total Electricity consumption (A)
1,20,83,485
1,57,90,891
Total Fuel consumption (B)
31,236
30,455
Energy consumption through other sources (C)
-
-
Total Energy consumption (A+B+C)
1,21,14,721
1,58,21,346
Energy intensity per rupee of turnover (Total Energy 
Consumption/ Turnover in rupees)
113.642 GJ/Lakhs Rs.
141.624 GJ/Lakhs Rs.
Energy intensity (optional) – The relevant metric may be 
selected by the entity
EI-1. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency:
No
Trade (PAT) Scheme of the Government of India? (Y/N) If yes, disclose whether targets set under the PAT scheme have been 
achieved. In case targets have not been achieved, provide the remedial action taken, if any:
No
EI-3. Provide details of the following disclosures related to water, in the following format: Water withdrawal by source (in 
kilolitres)
(KL)
Parameter
FY 2022-23
FY 2021-22
Water Withdrawal by Source (in kilolitres)
(i)   Surface water
NA
NA
(ii)  Groundwater
 12,13,600
 11,10,000
(iii) Third party water
 4,92,000
 4,90,000
(iv) Seawater / desalinated water
NA
NA
(v)  Others
Total volume of water withdrawal (in kilolitres) (i + ii + iii + 
iv + v)
17,05,600
16,00,000
Metropolis Healthcare Limited
98
(KL)
Parameter
FY 2022-23
FY 2021-22
Total volume of water consumption (in kilolitres)
17,05,600
16,00,000
Water intensity per rupee of turnover (Water consumed / 
turnover)
15.999 KL/Lakhs Rs.
14.322 KL/Lakhs Rs.
Water intensity (optional) – the relevant metric may be 
selected by the entity. KL /  Lakh
EI-3. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency-
No
EI-4. Has the entity implemented a mechanism for Zero Liquid Discharge? If yes, provide details of its coverage and 
implementation.
No
EI- 5. Please provide details of air emissions (other than GHG emissions) by the entity, in the following format:
Parameter
Please specify unit
Current Financial Year
Previous Financial Year
NOx
-
-
-
Sox
-
-
-
Particulate matter (PM)
-
-
Persistent organic pollutants (POP)
-
-
-
Volatile organic compounds (VOC)
-
-
-
Hazardous air pollutants (HAP)
-
-
-
Others – please specify
-
-
-
EI-5. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency: 
No
EI-6. Provide details of greenhouse gas emissions (Scope 1 and Scope 2 emissions) & its intensity, in the following format:
Parameter
Unit
FY 2022-23
FY 2021-22
Total Scope 1 emissions (Break-up of the 
GHG into CO2, CH4, N2O, HFCs, PFCs, SF6, 
NF3, if available)
Metric tonnes of 
CO2 equivalent
56.29  
-
Total Scope 2 emissions (Break-up of the 
GHG into CO2, CH4, N2O, HFCs, PFCs, SF6, 
NF3, if available)
Metric tonnes of 
CO2 equivalent
6,258.04  
-
Total Scope 1 and Scope 2 emissions per 
rupee of turnover
Metric tonnes of CO2 
equivalent / rupee of 
turnover
0.059/Lakhs Rs.
-
Total Scope 1 and Scope 2 emission 
intensity (optional) – the relevant metric 
may be selected by the entity
Metric tonnes of CO2 
equivalent /  rupee of
turnover
-
-
Statutory 
Reports
Annual Report 2022-23
99
EI-6. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency:
No
EI-7. Does the entity have any project related to reducing Green House Gas emission? If Yes, then provide details:
No
EI-8. Provide details related to waste management by the entity, in the following format:
(Metric Tonnes)
Parameter
FY 2022-23
FY 2021-22
Total Waste generated (in metric tonnes)
Plastic waste (A)
25,202
E-waste(B)
41
Bio-medical waste (C)
3,28,681
3,01,245
Construction and demolition waste (D)
23,400
31,000
Battery waste (E)
588
1,603
Radioactive waste (F)
NA
NA
Other Hazardous waste
Please specify, if any. (G)
NA
NA
Other Non-hazardous waste generated (H). Please specify, 
if any.(Break-up by composition i.e. by materials relevant to 
the sector)
-
-
Total (A + B + C + D + E + F + G + H)
3,77,912
3,33,848
For each category of waste generated, total waste 
recovered through recycling, re-using or other recovery 
operations (in metric tonnes)
Category of waste – Plastic
(i)    Recycled
No Recycling
No Recycling
(ii)   Re-used
Not reused
Not reused
(iii)  Other recovery operations
Batteries, Construction 
waste and biomedical waste 
are disposed of through an 
authorized service provider
Batteries, Construction 
waste, and biomedical waste 
are disposed of through an 
authorized service provider
Total
-
-
Category of waste - E-Waste
(i)    Recycled
(ii)   Re-used
(iii)  Other recovery operations
Total
-
-
Category of waste - Bio-medical waste
(i)   Recycled
(ii)  Re-used
(iii) Other recovery operations
Total
-
-
Metropolis Healthcare Limited
100
(Metric Tonnes)
Parameter
FY 2022-23
FY 2021-22
Category of waste - Construction and demolition waste
(i)   Recycled
(ii)  Re-used
(iii) Other recovery operations
Total
-
-
Category of waste - Battery waste
(i)   Recycled
(ii)  Re-used
(iii) Other recovery operations
Total
-
-
Category of waste - Radioactive waste
(i)    Recycled
(ii)   Re-used
(iii)  Other recovery operations
Total
-
-
Category of waste - Other Hazardous waste
(i)    Recycled
(ii)   Re-used
(iii)  Other recovery operations
Total
-
-
Category of waste - Other Non-Hazardous waste
(i)    Recycled
(ii)   Re-used
(iii)  Other recovery operations
Total
-
-
For each category of waste generated, total waste 
disposed by nature of disposal method (in metric tonnes)
Category of waste – Plastic
(i)  Incineration
(iii) Other disposal operations
Total
-
-
Category of waste - E-Waste
(i)   Incineration
(iii)  Other disposal operations
Total
-
-
Statutory 
Reports
Annual Report 2022-23
101
(Metric Tonnes)
Parameter
FY 2022-23
FY 2021-22
Category of waste - Bio-medical Waste
(i)    Incineration
(iii)  Other disposal operations
Total
-
-
Category of waste - Construction and demolition waste
(i)   Incineration
(iii)  Other disposal operations
Total
-
-
Category of waste – Battery
(i)   Incineration
(iii) Other disposal operations
Total
-
-
Category of waste – Radioactive
(i)   Incineration
(iii)  Other disposal operations
Total
-
-
Category of waste - Other Hazardous waste. Please 
specify, if any
(i)    Incineration
(iii)  Other disposal operations
Total
-
-
Category of waste - Other Non-hazardous waste generated
(i)  Incineration
(iii)  Other disposal operations
Total
-
-
EI-8. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency. -
No
Metropolis Healthcare Limited
102
Leadership Indicators
LI-1. Provide break-up of the total energy consumed (in Joules or multiples) from renewable sources, in the following format:
Parameter
FY 2022-23
FY 2021-22
From Renewable Sources
Total Electricity consumption (A)
2,303.6
2,082.2
Total Fuel consumption (B)
NA
NA
Energy consumption through other sources (C)
NA
NA
Total Energy consumed from Renewable Sources (A+B+C)
2,303.6
2,082.2
your Company to reduce usage of hazardous and toxic chemicals in your products and processes and the practices adopted 
to manage such wastes:
The Company follows below detailed practices to reduce usage of hazardous and toxic chemicals:
a.
Housekeeping Chemicals – The Company uses non-toxic and environmentally friendly chemicals for cleaning. 
it of.
c.
Bio-medical waste – Waste is segregated into different colored bins and covers with barcodes and handed over to an 
authorized partner.
d.
Refrigerant - New Purchase done in R32 & R407 recommended by ASHRAE.
biosphere reserves, wetlands, biodiversity hotspots, forests, coastal regulation zones etc.) where environmental approvals / 
clearances are required, please specify details in the following format:
Sr. 
No.
Location of operations/
Type of operations
Whether the conditions of environmental approval / clearance 
are being complied with? (Y/N) If No, the reasons thereof and 
corrective action taken, if any.
1
-
-
-
EI-11. Details of environmental impact assessments of projects undertaken by the entity based on applicable laws, in the 
Sr. 
No.
Name and brief 
details of project
No.
Date
Whether conducted by 
independent external 
agency (Yes / No)
Results communicated 
in public domain 
(Yes / No)
Relevant 
Web-Link
1
-
-
-
-
-
Remarks: No, audit was conducted. All statutory norms were followed in terms of EHS.
EI-12. Is the entity compliant with the applicable environmental law/ regulations/ guidelines in India; such as the Water 
(Prevention and Control of Pollution) Act, Air (Prevention and Control of Pollution) Act, Environment protection act and rules 
thereunder (Y/N). If not, provide details of all such non-compliances, in the following format:
Sr. 
No.
Specify the law / regulation 
/ guidelines which was not 
complied with
Provide details 
of the non-
compliance
regulatory agencies such as pollution 
control boards or by courts
Corrective 
action taken, if 
any
1
-
-
-
-
Statutory 
Reports
Annual Report 2022-23
103
Parameter
FY 2022-23
FY 2021-22
From Non-Renewable Sources
Total Electricity consumption (D)
NA
NA
Total Fuel consumption (E)
NA
NA
Energy consumption through other sources (F)
NA
NA
Total energy consumed from non-renewable sources 
(D+E+F)
NA
NA
Remarks: Solar Power accounts for 30% of Energy Consumption at Global Reference Laboratory which is purchased through 
third-party sources.
LI-1. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency:
No
LI-2. Provide the following details related to water discharged: Water discharge by destination and level of treatment (in 
kilolitres):
Parameter
FY 2022-23
FY 2021-22
Water discharge by destination and level of treatment (in 
kilolitres)
(i)    To Surface water
- No treatment
NA
NA
- With treatment – please specify level of treatment          
NA
NA
(ii)   To Groundwater
- No treatment
NA
NA
- With treatment – please specify level of treatment          
NA
NA
(iii)  To Seawater
- No treatment
NA
NA
- With treatment – please specify level of treatment          
NA
NA
(iv)  Sent to third-parties
- No treatment
NA
NA
- With treatment – please specify level of treatment          
NA
NA
(v)  Others (Corporation Drainage)
- No treatment
2,07,000
No Data Available
- With treatment – please specify level of treatment          
7,53,300 (Through ETP Plant)
No Data Available
Total water discharged (in kilolitres)
LI-2. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency:
No
LI-3. Water withdrawal, consumption and discharge in areas of water stress (in kilolitres):
(i)
Name of the area:
The Company has laboratories in the following areas: Delhi, Mumbai, Chennai, Kolkata, and all upcountry sites.
(ii) 
Nature of operations:
Metropolis Healthcare Limited
104
(iii)
Water withdrawal, and consumption in the following format:
(KL)
Parameter
FY 2022-23
FY 2021-22
Water Withdrawal by Source (in kilolitres)
(i)    Surface water
NA
NA
(ii)   Groundwater
NA
NA
(iii)  Third party water
NA
NA
(iv) Seawater / desalinated water
NA
NA
(v)  Others
NA
NA
Total volume of water withdrawal (in kilolitres) (i + ii + iii + 
iv + v)
NA
NA
Total volume of water consumption (in kilolitres)
Water intensity per rupee of turnover (Water consumed / 
turnover)
-
-
Water intensity (optional) – the relevant metric may be 
selected by the entity.KL / Lakh
-
-
Water discharge by destination and level of treatment (in 
kilolitres)
(i)  To Surface water
- No treatment
-
-
- With treatment – please specify level of treatment              
NA
NA
(ii)  To Groundwater
- No treatment
NA
NA
- With treatment – please specify level of treatment              
(iii) To Seawater
- No treatment
- With treatment – please specify level of treatment              
(iv) Sent to third-parties
- No treatment
-
-
- With treatment – please specify level of treatment              
-
-
(v) Others
- No treatment
-
-
- With treatment – please specify level of treatment              
-
-
Total water discharged (in kilolitres)
-
-
LI-3. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency:
No
Statutory 
Reports
Annual Report 2022-23
105
LI-4. Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, 
name of the external agency:
No
LI-5. With respect to the ecologically sensitive areas reported at Question 10 of Essential Indicators above, provide details 
activities:
The Company doesn’t have any laboratories in ecologically sensitive areas.
well as outcome of such initiatives, as per the following format:
Sr. 
No.
Initiative Undertaken
Details of the Initiative (Web-Link, if any, 
May be Provided Along-with Summary)
Outcome of the Initiative
1
installation
close  to 8  locations  for minimizing the 
impact of  water pollution
before being discharged
2
CNG Kit installation
CNG Kits installed in 9 vehicles  for 
minimizing the impact of air pollution
Reduction in carbon footprint and green 
initiatives. Approximately, 2018 liters of 
fuel saved.
3
Elimination of disposable 
water bottles usage
Pet bottles & Jars were given to all 
employees and disposable water bottles 
were banned inside the organization
Reduction in plastic waste and supporting 
a green environment and conservation of 
water
4
Eco-friendly initiatives
Sustainability initiative by installing hand 
dryers
Reduction of C- fold usage across the 
country and elimination of paper waste
5
End of life AC replacement 
Old AC replaced with advanced, new-
technology refrigerant
minimize electricity consumption up to 
approximately 10% and support global 
warming
6
Third-party power 
procurement
30% of third-party power is generated 
through Solar & Wind
Renewable energy sources and reduction 
in carbon footprint
7
Usage of recycling paper
Procurement of eco-friendly paper for 
Conservation of trees and a 100% 
elemental chlorine-free product
LI-4. Please provide details of total Scope 3 emissions & its intensity, in the following format:
Parameter
Unit
FY 2022-23
FY 2021-22
Total Scope 3 emissions (Break-up of 
the GHG into CO2, CH4, N2O, HFCs, 
PFCs, SF6, NF3, if available)
Metric tonnes of CO2
equivalent
153
NA
Total Scope 3 emissions per rupee of 
turnover 
Metric tonnes of CO2
equivalent / rupee of 
turnover
0.0014 TCO2e/Lakh Rs.
NA
Total Scope 3 emission intensity 
(optional) – the relevant metric may be 
selected by the entity
Metric tonnes of CO2
equivalent / rupee of 
turnover
-
-
Metropolis Healthcare Limited
106
LI-7. Does the entity have a business continuity and disaster management plan? Give details in 100 words/ web link:
Metropolis has BCP and DR Plan in place which currently covers Global Reference Laboratory, Mumbai. In future, the plan is to 
include Regional Reference Laboratories across the country as well. Few points covered in the plan are as follows: -
interruptions
Monitoring measures in place
towards ESG
impact to the environment, arising from the 
value chain of the entity. What mitigation or 
adaptation measures have been taken by the 
entity in this regard: 
-
industry chambers/ associations: 
LI-9. Percentage of value chain partners (by 
value of business done with such partners) 
that 
were 
assessed 
for 
environmental 
impacts:
-
PRINCIPLE 7
and transparent
Essential Indicators
1
Statutory 
Reports
Annual Report 2022-23
107
Name of Authority
-
Brief of the Case
-
Corrective Action Taken
-
LI-1. Details of public policy positions advocated by the entity:
Sr. 
No.
Public Policy advocated
Method resorted 
for such advocacy
Whether 
information 
available in public 
domain? (yes/no)
Frequency of review by 
Board (Annually/ Half 
yearly/ Quarterly / Others – 
Please specify)
Web 
Link, if 
available
1
Leadership Indicators
PRINCIPLE 8
Businesses should promote inclusive growth and equitable development
Essential Indicators
EI-1. Details of Social Impact Assessments (SIA) of projects undertaken by the entity based on applicable laws, in the current 
Sr. 
No.
Name and brief 
details of project
SIA 
No.
Date of 
Whether conducted by 
independent external 
agency (Yes / No)
Results 
communicated in 
public domain (Yes 
/ No)
Relevant 
Web link
1
-
-
-
-
-
-
EI-2. Provide information on project(s) for which ongoing Rehabilitation and Resettlement (R&R) is being undertaken by your 
entity, in the following format:
Sr. 
No.
Name of Project 
for which R&R is 
ongoing
State
District
No. of Project 
Affected 
Families (PAFs)
% of PAFs Covered by 
R&R
Amounts Paid 
to PAFs in the 
FY (In Rs.)
1
-
-
-
-
-
-
EI-1.b. List the top 10 trade and industry chambers/ associations (determined based on the total members of such body) the 
Sr. 
No
Name of the Trade and Industry Chambers/Associations
Reach of Trade and Industry Chambers/Associations 
(State/National)
1
NATHealth (Healthcare Federation of India)
National
EI-2. Provide details of corrective action taken or underway on any issues related to anti-competitive conduct by the entity, 
based on adverse orders from regulatory authorities:
Metropolis Healthcare Limited
108
EI-3. Describe the mechanisms to receive and redress grievances of the community:
The Company is in the process of developing a mechanism to address community grievances.
EI-4. Percentage of input material (inputs to total inputs by value) sourced from suppliers:
Category
Current Financial Year
Previous Financial Year
Directly sourced from MSMEs/ small producers.
20%
17%
Sourced directly from within the district and neighboring 
districts.
-
LI-3.a. Do you have a preferential procurement policy where you give preference to purchase from suppliers comprising 
marginalized /vulnerable groups? (Yes/No)-
No
LI-3.b. From which marginalized /vulnerable groups do you procure?: NA
Leadership Indicators
(Reference: Question 1 of Essential Indicators above):
LI-2. Provide the following information on CSR projects undertaken by your entity in designated aspirational districts as 
Not Applicalbe
Corrective Action Taken
Not Applicalbe
State
-
Aspirational District
-
Amount Spent (In Rs.)
-
LI-3.c. What percentage of total procurement 
(by value) does it constitute?: 
NA
Statutory 
Reports
Annual Report 2022-23
109
Intellectual Property based on 
Traditional Knowledge
-
Basis of Calculating 
-
Owned/ Acquired 
(Yes/No)
-
(Yes / No)
-
LI-5. Details of corrective actions taken or underway, based on any adverse order in intellectual property related disputes 
wherein usage of traditional knowledge is involved.
Name of Authority
-
Brief of the Case
-
Corrective Action Taken
-
Sr. 
No.
CSR Project
from CSR Projects
and marginalized groups
1
Too Shy To Ask (TSTA) 
for Adolescent Well-Being 
 1,41,920 
 95%
2
Preventative Health Care Projects 
3,00,00,00 
 100% 
3
MedEngage 
 2,672
  90%
PRINCIPLE 9
Businesses should engage with and provide value to their consumers in a responsible manner
Essential Indicators
EI-1. Describe the mechanisms in place to receive and respond to consumer complaints and feedback- 
Customers can register complaints through the Company’s website, dedicated email (support@metropolisindia.com), call center 
and patient service centers. All the complaints are logged in the complaint log, resolved, and communicated to the customers.
Documentation of RCA (Root Cause Analysis)/ CAPA (Corrective Action and Preventive Action) is done as well in the logger 
application.
EI-2. Turnover of products and/ services as 
a percentage of turnover from all products/
service that carry information about:
NA
Metropolis Healthcare Limited
110
Category
Number
Voluntary Recalls
-
NA
Forced Recalls
-
NA
Reasons for recall
EI-5. Does the entity have a framework/ policy on cyber security and risks related to data privacy? (Yes/No) If available, 
provide a web-link of the policy:
Yes, the Company has a policy on cyber security, and the link to the same is mentioned below
https://www.metropolisindia.com/newdata/Investors/code-of-conduct/Information%20Security%20Policy.pdf
No such cases
EI-6. Provide details of any corrective actions 
taken or underway on issues relating to 
advertising, and delivery of essential services; 
cyber security and data privacy of customers; 
re-occurrence of instances of product recalls; 
penalty / action taken by regulatory authorities 
on safety of products / services: 
Category
As a percentage to total turnover
Environmental and Social Parameters relevant to the Product
 --
Safe and Responsible Usage
--
Recycling and/or Safe Disposal
--
EI-3. Number of consumer complaints in respect of the following:
FY 2022-23
FY 2021-22
Received 
during the 
year
Pending 
Resolution 
at the end 
of the year
Remarks
Received 
during the 
year
Pending 
Resolution 
at end of 
year
Remarks
Data privacy
 0
0
0
0
Advertising
Cyber-Security
 0
0
0
0
Delivery of Essential Services
Please refer to Q.23 of Section A for complaints/queries received regarding the delivery/
non-delivery of essential services
Restrictive Trade Practices
 0
0
0
0
Unfair Trade Practices
 0
0
0
0
Other
EI-4. Details of instances of product recalls on account of safety issues:
Statutory 
Reports
Annual Report 2022-23
111
LI-1. Channels / platforms where information on products and services of the entity can be accessed (provide web link, if 
available): 
www.metropolisindia.com), patient mobile app, by dialing its 
customer care number or by walking up to the local center. 
Leadership Indicators
LI-2. Steps taken to inform and educate 
consumers about safe and responsible usage 
of products and/or services:
All of the Company’s centers have banners 
promoting prudent and safe use of its services. 
sample collection procedure-related videos, 
of diagnostic tests available for consumers of 
all ages are posted on a regular basis on the 
Company’s YouTube Channel.
LI-3. Mechanisms in place to inform consumers of any risk of disruption/discontinuation of essential services:
Relevant Communication processes are in place.
LI-4. Does the entity display product information on the product over and above what is mandated as per local laws? (Yes/
No/Not Applicable) If yes, provide details in brief. Did your entity carry out any survey with regard to consumer satisfaction 
(Yes/No):
Metropolis brand. The metric is used to gauge customer loyalty and satisfaction in order to improve its services. The current Net 
Promoter Score is 85.
LI-5. Provide the following information relating to data breaches: 
a. 
Number of instances of data breaches along-with impact:
 
No data breaches were reported during the period under review.
 
Not applicable
